Encainidum [Latin] en es it fr

Encainidum [Latin] Brand names, Encainidum [Latin] Analogs

Encainidum [Latin] Brand Names Mixture

  • No information avaliable

Encainidum [Latin] Chemical_Formula

C22H28N2O2

Encainidum [Latin] RX_link

No information avaliable

Encainidum [Latin] fda sheet

Encainidum [Latin] msds (material safety sheet)

Encainidum [Latin] Synthesis Reference

No information avaliable

Encainidum [Latin] Molecular Weight

352.47 g/mol

Encainidum [Latin] Melting Point

No information avaliable

Encainidum [Latin] H2O Solubility

No information avaliable

Encainidum [Latin] State

Solid

Encainidum [Latin] LogP

4.427

Encainidum [Latin] Dosage Forms

No information avaliable

Encainidum [Latin] Indication

For management of irregular heartbeats to a normal rhythm.

Encainidum [Latin] Pharmacology

Used to treat irregular heartbeats, encainide decreases excitability, conduction velocity, and automaticity as a result of slowed atrial, atrioventricular (AV) nodal, His-Purkinje, and intraventricular conduction. It causes a slight but significant prolongation of refractory periods in these tissues. The greatest effect is on the His-Purkinje system. Encainide decreases the rate of rise of the action potential without markedly affecting its duration.

Encainidum [Latin] Absorption

No information avaliable

Encainidum [Latin] side effects and Toxicity

No information avaliable

Encainidum [Latin] Patient Information

No information avaliable

Encainidum [Latin] Organisms Affected

Humans and other mammals